The association between low body mass index (BMI) and poor prognosis in patients with
chronic obstructive pulmonary disease (COPD) is a common clinical observation. We …

Background Epidemiological studies have reported that patients with type 2 diabetes mellitus
(DM) have increased mortality and morbidity from cardiovascular diseases, independent of …

Rationale: Low body mass index (BMI) is a marker of poor prognosis in chronic obstructive
pulmonary disease (COPD). In the general population, the harmful effect of low BMI is due to …

Background Patients with type 2 diabetes mellitus (T2D) have an increased risk of cardiovascular
disease and mortality compared to the background population. Observational studies …

Objective To assess the effect of targeting intensive glycaemic control versus conventional
glycaemic control on all cause mortality and cardiovascular mortality, non-fatal myocardial …

Background The combination of insulin and glucagon-like peptide-1 (GLP-1) receptor
agonist therapy improves glycaemic control, induces weight loss, and reduces insulin dose …

The sex-specific and age-specific incidence rates of the major parenchymal liver diseases in
a North European population were estimated using a computerized registry of all …

Aims To examine the prevalence of micro- and macrovascular complications and their
associated clinical characteristics at time of type 2 diabetes (T2D) diagnosis. Methods We …

Background Guidelines recommend metformin as the first-line oral treatment for type 2
diabetes. We conducted a systematic review to assess whether the use of second- and third-…

Background Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether
sulphonylureas show better, equal or worse therapeutic effects in comparison with other …